Jun 05, 2017 - New competition could slow prescription growth for Linzess and take some of the luster off this small-cap biotech stock.
May 25, 2017 - Aerie Pharmaceuticals, Inc. (AERI) announced positive primary efficacy results of the 90-day phase III registration trial -- Mercury 2 -- for its pipeline candidate Roclatan.
May 22, 2017 - Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
May 22, 2017 - Agnes Scott College President Elizabeth Kiss sent an email to the institution’s alumnae announcing her intention to resign on June 30, 2018 – completing a dozen years at the helm of the Decatur liberal arts women’s college.
“Agnes Scott is a magical place, and I feel so blessed to have had the privilege of serving as your president for the past 11 years,” Kiss wrote in her email. “From the moment I first read Agnes Scott’s powerful mission statement, I felt a deep sense of connection…
May 19, 2017 - Amgen Inc. (AMGN) recently announced the submission of a biologics license application (BLA) to the FDA for its pipeline candidate erenumab (AMG 334) for the prevention of migraine.
May 17, 2017 - Allergan plc (AGN) announced that Health Canada approved Viberzi (eluxadoline) for the treatment of adults suffering with irritable bowel syndrome with diarrhea (IBS-D)
May 17, 2017 - Cardiome Pharma Corp. (CRME) reported loss of 20 cents per share in first quarter of 2017. Reported loss is wider than both the Zacks Consensus Estimate of a loss of 15 cents and year-ago loss of 9 cents.
May 16, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S.
May 12, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) reported first-quarter 2017 earnings of $1.03 per share (including equity compensation expenses), which was in line with the Zacks Consensus Estimate.
May 11, 2017 - The specialty and generic drugmaker gets another boost from its 2016 purchase of Actavis Generics from Allergan.